强生收购Novira Therapeutics

HBVCURER

http://seekingalpha.com/news/2894476-johnson-and-johnson-buys-clinical-stage-developer-of-hbv-antivirals


Johnson & Johnson buys clinical stage developer of HBV antivirals[size=0.95em]Nov 4 2015, 12:48 ET | About: [color=rgb(2, 73, 153) !important]Johnson & Johnson (JNJ) | By: [color=rgb(2, 73, 153) !important]Douglas W. House, SA News Editor

Johnson & Johnson (JNJ) acquiresprivately held Novira Therapeutics, a clinical stage biopharmaceutical firm developing therapies to cure chronic hepatitis B infection within one year of treatment, for an undisclosed sum. The transaction should close this quarter.

Novira's lead product candidate is NVR 3-778, a orally available, small molecule, direct-acting antiviral that inhibits the HBV core or capsidprotein. HBV core is an attractive drug target since it is plays a key role in viral replication and survival. NVR 3-778 disrupts the HBV life cycle by inducing the assembly of defective capsids. According to the company, its inhibitors, when used in combination with current standard-of-care drugs (nucleosides and interferon), should deliver greater and faster suppression of viral DNA and new virus production.

Selected HBV-related tickers: (ARWR +2.1%)(GILD -1%)(CTRV -3.2%)(ABUS+2.6%)(DVAX -1.8%)(MRK +0.7%)(SNY -0.8%)(GSK +0.1%)(ISIS +2.1%)(ALNY+3.1%)(BMY -0.6%)

HBVCURER

百年老店耐不住寂寞，也加入到Anti-HBV的浪潮里了

至于收购本身，醉翁之意不在酒也。

ivanich

强生收购的这个公司亮点何在？

newchinabok

我个人对nvr3-778四个期待，防耐药，降肝癌，减cccdna，成为今后药物组合之一

MP4

关键收购后研发目标改不改，有很多药被收购后就终止研发了。

newchinabok

别把人往坏里想，你以为都是黑社会。洪恫县里无好人，上演乙肝版的玉堂春呀

newchinabok

是封杀药物赚钱还是药物开发出来赚钱？只有神经病才会封杀，又没和强生药物冲突，有类似药物冲突，有可能封杀

zgct

MP4 发表于 2015-11-5 15:33
关键收购后研发目标改不改，有很多药被收购后就终止研发了。

这个商业行为是有可能的！也会常发生

zgct

newchinabok 发表于 2015-11-5 12:20
我个人对nvr3-778四个期待，防耐药，降肝癌，减cccdna，成为今后药物组合之一 ...

属于免疫类药吗？

zgct

感谢楼主分享释议，
属于免疫类药吗？可以，降肝癌，减cccdna？